No tumor-free waiting period after treatment of multilocular cystic renal cell carcinoma: A new case and review of the literature

Ekamol Tantisattamo, April Elam, Jason Cobb, Carla LaShannon Ellis, James L. Bailey*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Most pretransplant malignancies require a tumor-free waiting period before transplantation. End-stage renal disease (ESRD) patients have an increased risk of renal cell carcinoma (RCC), which is mostly detected from routine screening during pre-kidney transplant evaluation. RCC must be quiescent prior to kidney transplantation. However, the tumor-free waiting period for RCC varies depending on the types of RCC. Multilocular cystic RCC (MCRCC), one subtype of clear cell RCC, has low malignant potential and may not require a tumor-free waiting period. We report a case of an ESRD patient with a newly diagnosed MCRCC that was found during routine pre-kidney transplant evaluation. A plan for kidney transplantation within 6 months of successful tumor removal by nephrectomy was made. The literature regarding MCRCC in kidney transplantation is reviewed.

Original languageEnglish (US)
Pages (from-to)151-156
Number of pages6
JournalAmerican Journal of Nephrology
Volume40
Issue number2
DOIs
StatePublished - May 22 2014

Keywords

  • Kidney transplant
  • Multilocular cystic renal cell carcinoma
  • Renal cell carcinoma
  • Tumor-free waiting period

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'No tumor-free waiting period after treatment of multilocular cystic renal cell carcinoma: A new case and review of the literature'. Together they form a unique fingerprint.

Cite this